Non-interventional Observational Study With Pramipexole: Impact on Non-motor Symptoms in Parkinson's Disease
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Idiopathic Parkinsons disease with or without fluctuations
Indication for treatment with Sifrol®
Male or female patients of age
Presence of at least mild depressive symptoms (as judged by the treating physician)
Ability to reliably complete a self-rating scale (HADS)
Any contraindications according to the Summary of Product Characteristics (SPC): hypersensitivity to pramipexole or to any of the excipients.